| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | — | +61.9% |
| Cost of Revenue | $1.5M | — | +37.3% |
| Gross Profit | $940K | — | +123.8% |
| R&D Expense | $239K | — | +191.5% |
| SG&A Expense | $1.2M | — | +46.5% |
| Operating Income | -$1.4M | — | -32.6% |
| Pre-tax Income | -$1.5M | — | -39.2% |
| Net Income | -$1.5M | — | -39.2% |
| EPS (Basic) | -$0.31 | — | +39.2% |
| EPS (Diluted) | -$0.31 | — | +39.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $654K | -71.6% | -82.3% |
| Accounts Receivable | $890K | -26.7% | +66.7% |
| Inventory | $3.4M | +12.4% | +36.2% |
| Current Assets | $6.2M | -20.0% | -20.7% |
| Total Assets | $8.5M | -16.8% | -3.0% |
| Current Liabilities | $3.7M | -11.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.1M | — | -63.2% |
| Capital Expenditures | $46K | — | — |
| Investing Cash Flow | -$46K | — | — |
| Financing Cash Flow | $453K | — | +376.8% |
| Free Cash Flow | -$2.1M | — | — |
| +41.7% |
| Long-term Debt | $788K | -5.2% | +492.5% |
| Total Liabilities | $4.5M | -10.2% | +66.6% |
| Stockholders' Equity | $4.0M | -23.3% | -34.4% |